Following the departure of Vinay Prasad, M.D., former head of the Center for Biologics Evaluation and Research (CBER), the FDA has already tapped someone else to temporarily fill his shoes.
FDA Taps George Tidmarsh as Acting CBER Leader
Comment
Show comments
Hide Comments
